Scholars Central

PerspectivePublished 30 Apr 2025

The Future of Cervical Cancer Treatment: Integrating Targeted Molecular Therapies and Immunotherapy

Authors: Nia Thompson

School of Oncology, Faculty of Clinical Sciences, University of Cape Town, Cape Town, South Africa

Cervical Cancer: Open Access

Volume 10 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cervical cancer remains a significant global health challenge, particularly in low-resource settings where access to preventive measures and treatment options is limited. While traditional therapies such as surgery, chemotherapy, and radiotherapy have been effective, they often come with significant side effects and limitations in advanced or recurrent cases. The integration of targeted molecular therapies and immunotherapy represents a promising frontier in cervical cancer treatment, offering precision, reduced toxicity, and improved outcomes. This article explores the methodologies, results, and implications of these innovative approaches, highlighting their transformative potential in the fight against cervical cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCervical Cancer: Open Access
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Nia Thompson”